These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2665864)

  • 41. Allogeneic bone marrow transplantation in irradiated adult rabbits.
    Bigelow CL; Adler LT; Appelbaum FR
    Transplantation; 1987 Sep; 44(3):351-4. PubMed ID: 3307059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation.
    Down JD; Tarbell NJ; Thames HD; Mauch PM
    Blood; 1991 Feb; 77(3):661-9. PubMed ID: 1991176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetal liver cell transplantation in dogs: results with DLA-compatible and incompatible grafts.
    Champlin R; Cain G; Stitzel KA; Gale RP
    Prog Clin Biol Res; 1985; 193():195-204. PubMed ID: 2868458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
    Sandmaier BM; Bethge WA; Wilbur DS; Hamlin DK; Santos EB; Brechbiel MW; Fisher DR; Storb R
    Blood; 2002 Jul; 100(1):318-26. PubMed ID: 12070043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
    Storb R; Raff R; Deeg HJ; Graham T; Appelbaum FR; Schuening FG; Shulman H; Seidel K; Leisenring W
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):961-6. PubMed ID: 9531382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
    Sandmaier BM; Fukuda T; Gooley T; Yu C; Santos EB; Storb R
    Exp Hematol; 2003 Feb; 31(2):168-75. PubMed ID: 12591282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation.
    Luznik L; Engstrom LW; Iannone R; Fuchs EJ
    Biol Blood Marrow Transplant; 2002; 8(3):131-8. PubMed ID: 11939602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporin-A abrogates transfusion-induced sensitization and prevents marrow graft rejection in DLA-identical canine littermates.
    Storb R; Deeg HJ; Atkinson K; Weiden PL; Sale G; Colby R; Thomas ED
    Blood; 1982 Aug; 60(2):524-6. PubMed ID: 7046849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
    Deeg HJ; Storb R; Thomas ED
    Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation.
    Schuening FG; Storb R; Goehle S; Graham TC; Appelbaum FR; Hackman R; Souza LM
    Blood; 1989 Sep; 74(4):1308-13. PubMed ID: 2475186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
    Schumm M; Günther W; Kolb HJ; Rieber P; Büttner M; Voss C; Kremmer E; Reitmeier P; Thierfelder S; Wilmanns W
    Tissue Antigens; 1994 Mar; 43(3):170-8. PubMed ID: 7522357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
    Schuening FG; Appelbaum FR; Deeg HJ; Sullivan-Pepe M; Graham TC; Hackman R; Zsebo KM; Storb R
    Blood; 1993 Jan; 81(1):20-6. PubMed ID: 7678065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
    Raff RF; Storb R; Graham T; Fidler JM; Sale GE; Johnston B; Deeg HJ; Pepe M; Schuening F; Appelbaum FR
    Transplantation; 1992 Nov; 54(5):813-20. PubMed ID: 1440847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of radiation-resistant large granular lymphocytes in the rejection of unrelated DLA-nonidentical marrow grafts in dogs.
    Raff RF; Loughran TP; Deeg HJ; Aprile JA; Graham TC; Sale GE; Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2718-20. PubMed ID: 3079094
    [No Abstract]   [Full Text] [Related]  

  • 59. Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate.
    Deeg HJ; Sale GE; Storb R; Graham TC; Schuening F; Appelbaum FR; Thomas ED
    Transplantation; 1987 Sep; 44(3):340-5. PubMed ID: 3307057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
    Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
    Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.